SG11202005556SA - Infection-related preterm birth diagnostic method - Google Patents

Infection-related preterm birth diagnostic method

Info

Publication number
SG11202005556SA
SG11202005556SA SG11202005556SA SG11202005556SA SG11202005556SA SG 11202005556S A SG11202005556S A SG 11202005556SA SG 11202005556S A SG11202005556S A SG 11202005556SA SG 11202005556S A SG11202005556S A SG 11202005556SA SG 11202005556S A SG11202005556S A SG 11202005556SA
Authority
SG
Singapore
Prior art keywords
infection
diagnostic method
preterm birth
related preterm
birth
Prior art date
Application number
SG11202005556SA
Inventor
Jeffrey Keelan
Matthew Scott Payne
Original Assignee
Univ Western Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017904748A external-priority patent/AU2017904748A0/en
Application filed by Univ Western Australia filed Critical Univ Western Australia
Publication of SG11202005556SA publication Critical patent/SG11202005556SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/30Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/335Assays involving biological materials from specific organisms or of a specific nature from bacteria from Lactobacillus (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202005556SA 2017-11-24 2018-11-22 Infection-related preterm birth diagnostic method SG11202005556SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017904748A AU2017904748A0 (en) 2017-11-24 Infection-Related Preterm Birth Diagnostic Method
AU2018903531A AU2018903531A0 (en) 2018-09-20 Infection-Related Preterm Birth Diagnostic Method
PCT/AU2018/051249 WO2019100113A1 (en) 2017-11-24 2018-11-22 Infection-related preterm birth diagnostic method

Publications (1)

Publication Number Publication Date
SG11202005556SA true SG11202005556SA (en) 2020-07-29

Family

ID=66631247

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005556SA SG11202005556SA (en) 2017-11-24 2018-11-22 Infection-related preterm birth diagnostic method

Country Status (9)

Country Link
US (1) US20210172005A1 (en)
EP (1) EP3714061A4 (en)
JP (1) JP2021514611A (en)
KR (1) KR20200095494A (en)
CN (1) CN111655863A (en)
CA (1) CA3085473A1 (en)
SG (1) SG11202005556SA (en)
WO (1) WO2019100113A1 (en)
ZA (1) ZA202003673B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016000539A1 (en) * 2014-06-30 2016-01-07 The Chinese University Of Hong Kong Detecting bacterial taxa for predicting adverse pregnancy outcomes
WO2016095789A1 (en) * 2014-12-15 2016-06-23 The Chinese University Of Hong Kong Detecting bacterial taxa for predicting preterm birth after clinical intervention
CN106350581B (en) * 2015-07-13 2020-09-18 山东朱氏药业集团有限公司 Method for detecting bacterial vaginitis by using detection kit
EP3334437A1 (en) * 2015-08-25 2018-06-20 Kaleido Biosciences, Inc. Glycan compositions and uses thereof

Also Published As

Publication number Publication date
EP3714061A4 (en) 2021-08-11
EP3714061A1 (en) 2020-09-30
ZA202003673B (en) 2024-03-27
WO2019100113A1 (en) 2019-05-31
AU2018373494A1 (en) 2020-07-02
JP2021514611A (en) 2021-06-17
RU2020120280A3 (en) 2022-01-14
CN111655863A (en) 2020-09-11
US20210172005A1 (en) 2021-06-10
CA3085473A1 (en) 2019-05-31
KR20200095494A (en) 2020-08-10
RU2020120280A (en) 2021-12-27

Similar Documents

Publication Publication Date Title
IL260678B (en) Systems and methods for improving disease diagnosis
EP3288455C0 (en) Diagnostic methods
PL3391041T3 (en) Automated clinical diagnostic system and method
IL253728A0 (en) Methods and compositions for diagnosing brain injury or neurodegeneration
GB201608459D0 (en) Diagnostic methods and kits
EP3305483A4 (en) Fault diagnosis device and fault diagnosis method
PL3421993T3 (en) Diagnostic method, and device for executing same
HK1251022A1 (en) Diagnostic methods
GB201700472D0 (en) Diagnostic test performance control system and method
GB201819116D0 (en) Repair diagnostic system and method
GB201507827D0 (en) Diagnostic test
HRP20210070T8 (en) Diagnostic device and related method
GB201711782D0 (en) Diagnostic and Prognostic methods
IL267982A (en) Diagnostic
GB201620348D0 (en) Remote diagnosis system and method for operating the same
PL3358944T3 (en) Diagnostic apparatus and testing method
GB201508860D0 (en) Diagnostic method
GB201409851D0 (en) Diagnostic method
GB201703406D0 (en) Diagnostic and prognostic methods
GB201615753D0 (en) Diagnostic method
GB2556001B (en) Diagnostic kits
GB2526426B (en) Electrical apparatus and diagnostic method
GB201510676D0 (en) Novel diagnostic and therapeutic method
SG11202005556SA (en) Infection-related preterm birth diagnostic method
GB201500875D0 (en) Antibodies for treatment and diagnosis